Bluehole Releases Industry Comment on China’s First Enterprise Risk Assessment Lab for EUTPD Compliance

Content of the article

SHENZHEN, China – China’s leading vaping media outlet, Bluehole New Consumption, today released an industry commentary on China’s first enterprise risk assessment lab for compliance with the European Union’s Directive on tobacco products.

Content of the article

Below is the full article:

SMOORE, a global leader in providing vaping technology solutions, today announced an industry-leading risk assessment laboratory for compliance with the European Tobacco Products Directive (EUTPD). Thus, SMOORE has become the first Chinese company capable of providing vaping products with one-stop TPD risk assessment service. Belonging to the SMOORE Basic Research Center, the lab will be a hub to enable more vaping brands to comply with EUTPD safety standards, thus meeting the vape market entry requirements of the EU.

This lab started operating in the first half of 2021 and has already performed 52 product tests for several leading vaping brands in the world. As the first TPD-compliant enterprise risk assessment lab in China, it can generate test reports within 5 working days. Its lab equipment is benchmarked against world-class analytical testing labs, such as Labstat and Enthalpy.

Coming into force in 2014, the TPD is a unified guideline for tobacco regulation in the 27 EU member states. It regulates the sale, presentation and manufacture of all tobacco products, including electronic cigarettes, in the EU. In the interest of quality control and protection of public health, the TPD sets specific safety requirements for the content of electronic cigarettes, such as the concentration of nicotine, heavy metals, carbonyl, aldehydes and ketones. , for products authorized to be placed on the EU market. .

As the second largest market for vaping products after North America, Europe has over 16.74 million adult vapers in 2022, with a market size of USD 5.58 billion (ECigIntelligence). Additionally, the regional vaping market size is expected to grow at a CAGR of 13.17% over the next 6 years.

With only one e-cigarette (Vuse Solo) approved by the US FDA through the PMTA (Premarket Tobacco Product Application) route so far, more and more vape brands are targeting the European market, considering its relatively user-friendly and its significant market potential.

As the industry benchmark for risk reduction and quality, SMOORE complies with its internal SMOORE 3.0 safety standards. Based on US EPA (Environmental Protection Agency) and PMTA risk assessment guidelines, SMOORE 3.0 covers all PMTA vapor safety tests and HPHCs (Harmful and Potentially Harmful Constituents) listed by the US FDA. In addition to vapor safety, SMOORE 3.0 also involves extractables and leachables from medical grade atomizing materials.

Content of the article

The SMOORE Basic Research Center has developed a comprehensive analytical testing and risk assessment system, covering non-clinical PMTA testing and health risk assessment. Accredited by the China National Accreditation Service for Conformity Assessment (CNAS) in 2019, it is now capable of performing up to 149 CNAS tests, involving chemical analysis of e-liquids and aerosols, electrical safety, material safety and battery safety.

Since FEELM, the flagship atomization technology brand owned by SMOORE, entered the EU market in 2018, SMOORE has partnered with several major vape brands in this region, including Vuse, HEXA, Innocigs and Alfapod. To date, vaping products featuring FEELM technologies have been exported to Belgium, the Netherlands, Estonia and Romania, with a leading market position in the UK, Germany and France.

To read the original article, please visit:

See the source version on



Chen Bianji


About Margaret Shaw

Check Also

BACK TO SCHOOL: Using e-cigarettes at school can help discipline

The impact of e-cigarettes on our schools In recent months, great steps have been taken …